Clinical Trial

The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study will evaluate the efficacy and safety of 627 in patients with UC.
Protocol Amendment History 1 change
critical Recruitment opened 2026-07-29
Trial Details
NCT Number NCT07507513
Lead Sponsor Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Conditions Ulcerative Colitis (UC)
Enrollment 288 participants
Start Date 2026-03-28
Primary Completion 2029-02-28 (estimated)
Study Completion 2029-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-28